BULLS ON THE HORIZON READY TO STAMPEDECC Pharma's revenue and margins are expected to have increased from a spike in sales and their new cannabis revenue stream. Canadian MJ sales were up 20% in March and April, with Aphria increasing market share for the last five quarters. Aphria's chart is also looking very bullish, with increasing new Robinhood investors, and 38M shares which have to be bought back by the shorts, share price should be breaking out with earnings. GLTA